ERBB2 and breast cancer: Indeed, PTP1B deficiency in HER2-activated mouse models leads to a significant delay in tumor progression and prevents metastasis [18], whereas overexpression of PTP1B in mammary glands of mice induces tumorigenesis, suggesting that enhanced PTP1B in itself is enough to confer breast cancer potential [17].